Dividend compounder review

CORT

Corcept Therapeutics Incorporated · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score43.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 15.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 19.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 1.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 7.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$99.7M
Free Cash Flow$141.8M
FCF Covers DividendUnknown
Debt / Equity1.51
P/E236.9
Revenue Growth 5Y16.6%
Net Margin6.2%
ROE7.2%
Price vs Trend55.2%
3Y Return279.3%
5Y Return264.6%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

CORT dividend review warning Warning · Warning

No usable dividend history found.